The Eli Lilly and Genmab-backed RNA drug developer is now valued at nearly $1.5bn following a decision to refocus on a coronavirus vaccine.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The banking management software provider has followed funding from ING in 2018 with $11.4m from Nordea and Crédit Agricole CIB.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Medical consultation platform developer Ubie has received $18.4m from medicine distributor Suzuken that will be used to enhance its apps, increase headcount and expand internationally.

Offshore wind technology developer Principle received funding from Tokyo Gas, which joined existing investors including EDP Ventures, Repsol and ASM Industries.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

An undisclosed investor provided the funding at a $4.3bn valuation, Marqeta having previously raised nearly $370m from backers including Commerzbank, Visa and CreditEase.

Cancer diagnostics technology developer Inivata has secured $25m from NeoGenomics to take its total funding to more than $128m.

Xiaomi has invested about $103m in a cash-and-shares deal that involved it increasing its stake in the power bank provider to almost 50%.